In another study, systems pharmacology modeling predicted multi-target interactions of resveratrol in AD, highlighting its regulatory effects on autophagy-related genes and its involvement in the PI3K/Akt/mTOR signaling axis (Li Y. et al., 2023). Here, AKT1 is linked to Alzheimer disease.